Expression profiles of miR3181 and miR199a in plasma and placenta of virally suppressed HIV-1 infected Cameroonian pregnant women at delivery

Human immunodeficiency virus (HIV)-1 infection during pregnancy reduces the transplacental transfer of protective maternal antibodies needed to confer immunity during early postnatal life. However, the mediation of MicroRNA in this dysregulation is not well understood MicroRNAs 3181 and 199a have been shown to mediate neonatal Fc receptor (FcRn)-like transmembrane antibody transfer and endocytosis respectively but their expression levels in the placenta and plasma in women living with HIV have not been extensively investigated. The objective of this study was to determine how the expression levels of miR-3181 and miR-199a in the placenta and plasma are affected in women chronically infected with HIV who are on antiretroviral therapy (ART) and are virally suppressed at delivery. In this pilot case-control study, plasma and placenta biopsies were obtained from 36 (18 HIV+ and 18 HIV-) Cameroonian women at delivery. MicroRNAs 3181 and 199a expression levels were measured using RT-qPCR, data was analyzed using SPSS22.0 and R 3.60, and p values below 0.05 were considered statistically significant. All the HIV-infected women were on known ART regimens and were virally suppressed. There was no significant difference in the levels of miR-3181 (p>0.05) in the placenta and plasma amongst HIV-infected and HIV uninfected women. The expression levels of miR-199a were significantly greater in the plasma compared to the placenta of HIV+ (p = 0.00005) and HIV- (p = 0.027) women. Moreover, there was a significantly higher (p = 0.02) level of miR-199a in the plasma of women with HIV and their uninfected counterparts. Linear regression models adjusted for systolic pressure showed no significant difference (p>0.05) in the levels of miR-199a and miR-3181 in both the placenta and plasma due to HIV infection. Our findings suggest that even though ART uptake and viral suppression might help in maintaining miR3181 and miR199a levels in the placenta of women with HIV at comparative levels to those of their HIV negative counterparts, the significantly higher levels of miR-199a in the plasma of women with HIV compared to the placenta might highlight lurking systemic dangers and requires further investigation.

[1]  V. Leroy,et al.  Effect of in utero exposure to HIV and antiretroviral drugs on growth in HIV-exposed uninfected children: a systematic review and meta-analysis protocol , 2019, BMJ Open.

[2]  J. Bigoga,et al.  Impact of HIV-1 infection on the IGF-1 axis and angiogenic factors in pregnant Cameroonian women receiving antiretroviral therapy , 2019, PloS one.

[3]  J. Blanco,et al.  Regulation of the Human Fc-Neonatal Receptor alpha-Chain Gene FCGRT by MicroRNA-3181 , 2018, Pharmaceutical Research.

[4]  S. Luchters,et al.  Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine , 2017, The Pediatric infectious disease journal.

[5]  Ava Kwong,et al.  miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer , 2016, BMC Cancer.

[6]  A. Marchant,et al.  The Immune System of HIV-Exposed Uninfected Infants , 2016, Front. Immunol..

[7]  A. Marchant,et al.  Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns , 2016, Front. Immunol..

[8]  C. Jones,et al.  HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. , 2016, The Lancet. Infectious diseases.

[9]  J. Singer,et al.  Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children , 2016, Front. Immunol..

[10]  J. Kazura,et al.  Maternal Human Immunodeficiency Virus-Associated Hypergammaglobulinemia Reduces Transplacental Transfer of Immunoglobulin G to Plasmodium falciparum Antigens in Cameroonian Neonates , 2016, Open forum infectious diseases.

[11]  Y. Sadovsky,et al.  MicroRNAs in placental health and disease. , 2015, American journal of obstetrics and gynecology.

[12]  L. Goedeke,et al.  The miR-199–dynamin regulatory axis controls receptor-mediated endocytosis , 2015, Journal of Cell Science.

[13]  G. Ashir,et al.  Transplacental Transfer of Macromolecules: Proving the Efficiency of Placental Transfer of Maternal Measles Antibodies in Mother: Infant Pairs , 2014, Annals of medical and health sciences research.

[14]  Gokul Swaminathan,et al.  MicroRNAs and HIV-1 infection: antiviral activities and beyond. , 2014, Journal of molecular biology.

[15]  Herren Wu,et al.  Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms , 2014, The Journal of Biological Chemistry.

[16]  Michael Golatta,et al.  Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer , 2013, PloS one.

[17]  W. Chan,et al.  Flexible and Versatile as a Chameleon—Sophisticated Functions of microRNA-199a , 2012, International journal of molecular sciences.

[18]  M. Carneiro-Sampaio,et al.  IgG Placental Transfer in Healthy and Pathological Pregnancies , 2011, Clinical & developmental immunology.

[19]  B. Gruhn,et al.  MicroRNA expression profiles of trophoblastic cells. , 2011, Placenta.

[20]  Jialing Huang,et al.  Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.

[21]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[22]  Mardge H. Cohen,et al.  Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. , 2006, Archives of internal medicine.